Rhodiola crenulata induces death and inhibits growth of breast cancer cell lines

Journal of Medicinal Food

Volumn 11, Issue 3, 2008, Pages 413-423

  Tu, Yifan ^a   Roberts, Louis ^a   Shetty, Kalidas ^a   Schneider, Sallie Smith ^a,b  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b Pioneer Valley Life Sciences Institute   (United States)

Author keywords

Breast cancer; Cell growth inhibition; Phenolic phytochemicals; Rhodiola

Indexed keywords

ANTINEOPLASTIC AGENT; PLANT EXTRACT; RHODIOLA CRENULATA EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER PREVENTION; CELL IMMORTALIZATION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG MEGADOSE; FEMALE; HUMAN; HUMAN CELL; LOW DRUG DOSE; MEDICINAL PLANT; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RHODIOLA CRENULATA; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CASPASES; CELL DEATH; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EPITHELIAL CELLS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM INVASIVENESS; PHENOLS; PHYTOTHERAPY; PLANT EXTRACTS; RHODIOLA; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS; RHODIOLA; RHODIOLA CRENULATA;

EID: 52149115859     PISSN: 1096620X     EISSN: None     Source Type: Journal    
DOI: 10.1089/jmf.2007.0736     Document Type: Article

References (22)

1. nd ed. (Shetty K, Paliyath G, Pometto AL, Levin RE, eds.). CRC Press, Boca Raton, FL, pp. 867-897.
2. Kelly GS: Rhodiola rosea: a possible plant adaptogen. Altern Med Rev 2001;6:293-302.
3. Ming DS, Hillhouse BJ, Guns ES, Eberding A, Xie S, Vimalanathan S, Towers GH: Bioactive compounds from Rhodiola rosea (Crassulaceae). Phytother Res 2005;19:740-743.
4. Salikhova RA, Aleksandrova IV, Mazurik VK, Mikhailov VF, Ushenkova LN, Poroshenko GG: Effect of Rhodiola rosea on the yield of mutation alterations and DNA repair in bone marrow cell. Patol Fiziol Eksp Ter 1997;4:22-24.
5. Udintsev SN, Shakhov VP: The role of humoral factors of regenerating liver in the development of experimental tumors and the effect of Rhodiola rosea extract on this process. Neoplasma 1991;38:323-331.
6. Bocharova OA, Matveev BP, Baryshnikov AI, Figurin KM, Serebriakova RV, Bodrova NB: The effect of a Rhodiola rosea extract on the incidence of recurrences of a superficial bladder cancer (experimental clinical research). Urol Nefrol (Mosk) 1995;2:46-47.
7. Band V, Zajchowski D, Kulesa V, Sager R: Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A 1990;87:463-437.
8. Malone W, Perloff M, Crowell J, Sigman C, Higley H: Fenretinide: a prototype cancer prevention drug. Expert Opin Investig Drugs 2003;12:1829-1842.
9. Degryse B, Resnati M, Rabbani SA, Villa A, Fazioli F, Blasi F: Src-dependence and pertussis-toxin sensitivity of urokinase receptor-dependent chemotaxis and cytoskeleton reorganization in rat smooth muscle cells. Blood 1999;94:649-662.
10. Shappell SB, Olson SJ, Hannah SE, Manning S, Roberts RL, Masumori N, Jisaka M, Boeglin WE, Vader V, Dave DS, Shook MF, Thomas TZ, Funk CD, Brash AR, Matusik RJ: Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma. Cancer Res 2003;63:2256-2267.
11. Zhang J, Tu Y, Smith-Schneider S: Activation of p53, inhibition of telomerase activity and induction of estrogen receptor beta are associated with the anti-growth effects of combination of ovarian hormones and retinoids in immortalized human mammary epithelial cells. Cancer Cell Int 2005;5:6.
12. Majewski N, Nogueira V, Bhaskar P, Coy P, Skeen J, Gottlob K, Chandel N, Thompson C, Robey R, Hay N: Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 2004;16:819-830.
13. Bras M, Queenan B, Susin SA: Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc) 2005;70:231-239.
14. Udintsev SN, Schakhov VP: Decrease of cyclophosphamide haematotoxicity by Rhodiola rosea root extract in mice with Ehrlich and Lewis transplantable tumors. Eur J Cancer 1991;27:182.
15. Udintsev SN, Krylova SG, Fomina TI: The enhancement of the efficacy of adriamycin by using hepatoprotectors of plant origin in metastases of Ehrlich's adenocarcinoma to the liver in mice. Vopr Onkol 1992;38:1217-1222.
16. Belieau A, Yaswen P: Soothing the watchman: telomerase reduces the p53-dependent cellular stress response. Cell Cycle 2007;11:1284-1287.
17. Zhou J, Zhou X, Tou Z, Xiao B, Chen S, Liu D: The effects on expressions of p53 and PCDNA by inhibition of hTERT with siRNA in transplantable modelhuman laryngeal squamous carcinoma in nude mice. Lin Chuang Er Bi Yan Hou Ke Za Zhi 2006;20:264-267.
18. Scaffidi C, Fulda S, Srinivasan A, Friesen C, Li F, Tomaselli KJ, Debatin KM, Krammer PH, Peter ME: Two CD95 (APO-1/Fas) signaling pathways. EMBO J 1998;17:1675-1687.
19. Sun XM, MacFarlane M, Zhuang J, Wolf BB, Green DR, Cohen GM: Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis. J Biol Chem 1999;274:5053-5060.
20. Kuwana T, Smith JJ, Muzio M, Dixit V, Newmeyer DD, Kornbluth S: Apoptosis induction by caspase-8 is amplified through the mitochondrial release of cytochrome c. J Biol Chem 1998;273:16589-16594.
21. Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES, Wang X: Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997;91:479-489.
22. Petak I, Houghton JA: Shared pathways: death receptors and cytotoxic drugs in cancer therapy. Pathol Oncol Res 2001;7:95-106.